SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067525
Filing Date
2014-11-13
Accepted
2014-11-13 12:21:10
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392478_10q.htm 10-Q 388119
2 EXHIBIT 31.1 v392478_ex31-1.htm EX-31.1 7365
3 EXHIBIT 31.2 v392478_ex31-2.htm EX-31.2 7344
4 EXHIBIT 32.1 v392478_ex32-1.htm EX-32.1 3398
5 EXHIBIT 32.2 v392478_ex32-2.htm EX-32.2 3459
  Complete submission text file 0001144204-14-067525.txt   4641984

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcli-20140930.xml EX-101.INS 747408
7 XBRL TAXONOMY EXTENSION SCHEMA bcli-20140930.xsd EX-101.SCH 49232
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20140930_cal.xml EX-101.CAL 22293
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20140930_def.xml EX-101.DEF 213819
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20140930_lab.xml EX-101.LAB 284199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20140930_pre.xml EX-101.PRE 238731
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 141217192
SIC: 2836 Biological Products, (No Diagnostic Substances)